Evaluation of Neutrophlil to Lymphocyte Ratio (NLR) in bronchiectasis exacerbation.
V. Georgakopoulou (Athens, Greece), K. Mantzouranis (Athens, Greece), D. Melemeni (Athens, Greece), G. Petsinis (Athens, Greece), D. Mermigkis (Athens, Greece), A. Lekkakou (Athens, Greece), E. Karakou (Athens, Greece), R. Chatzikyriakou (Athens, Greece), N. Trakas (Athens, Greece), X. Tsiafaki (Athens, Greece)
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Georgakopoulou (Athens, Greece), K. Mantzouranis (Athens, Greece), D. Melemeni (Athens, Greece), G. Petsinis (Athens, Greece), D. Mermigkis (Athens, Greece), A. Lekkakou (Athens, Greece), E. Karakou (Athens, Greece), R. Chatzikyriakou (Athens, Greece), N. Trakas (Athens, Greece), X. Tsiafaki (Athens, Greece). Evaluation of Neutrophlil to Lymphocyte Ratio (NLR) in bronchiectasis exacerbation.. 3337
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: